Lee, D. S., Austin, P. C., Farkouh, M. E., Jackevicius, C. A., Kwong, J. C., Yu, B., . . . Ha, A. Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: A cohort study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLee, Douglas S., et al. Association Between Dipeptidyl Peptidase-4 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists and COVID-19 Infection and Adverse Outcomes: A Cohort Study. BMJ Publishing Group.
MLA (9th ed.) CitationLee, Douglas S., et al. Association Between Dipeptidyl Peptidase-4 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists and COVID-19 Infection and Adverse Outcomes: A Cohort Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.